How to Buy Maze Therapeutics Stock
Maze Therapeutics Inc
Maze Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States.
Maze Therapeutics stock last closed at $22.52, down 3.92% from the previous day, and has decreased 4.09% in one year. It has overperformed other stocks in the Biotechnology industry by 0.18 percentage points. Maze Therapeutics stock is currently +2.32% from its 52-week low of $22.01, and -58.02% from its 52-week high of $53.65.
As of Sep 18, 2026, there are 55.55M shares of MAZE outstanding. The market cap of MAZE is $1.25B. In the last 24 hours, 1.5M MAZE shares were traded.
How to Buy Maze Therapeutics Stock
Wondering how to invest in Maze Therapeutics stock? Here's how.
- Figure out where to buy Maze Therapeutics stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Maze Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Pick your method of payment and add your info.
- Evaluate Maze Therapeutics stock: The Maze Therapeutics ticker symbol is MAZE. Is Maze Therapeutics stock a good investment? Should you buy shares of MAZE? How do MAZE's underlying business fundamentals look? Do top analysts think Maze Therapeutics is a good buy? Why has MAZE's stock price moved recently? (Hint: Our stock research tools can help you evaluate if MAZE is a good stock to buy).
- Place your MAZE buy order: Decide if you will purchase MAZE shares at the current market price or use a limit order to purchase MAZE stock at a particular price.
- Watch your investment in MAZE: Create a watchlist to the latest updates on your investment in Maze Therapeutics stock.
Step 1: Figure out where to buy Maze Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy MAZE shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you need to fill out some personal details so you are able to buy MAZE stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have finished signing up on a good online stock trading app, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help depositing funds into your new brokerage account.
Step 4: Evaluate Maze Therapeutics stock
After you have decided on the best place to buy Maze Therapeutics stock, it's crucial to evaluate their stock before you buy, so you truly understand the risk and upside.
Maze Therapeutics quick stats
Fundamentals of Maze Therapeutics
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on MAZE's stock page.
Is MAZE stock undervalued or overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge MAZE's intrinsic value.
Using relative valuations measures:
- MAZE may be undervalued based on its P/B ratio of 2.76x, relative to Biotechnology industry P/B ratio of 5.28x
You can access additional valuation analysis on MAZE's stock here.
MAZE Financial Health Summary
Positive Financial Indicators:
- MAZE has cash burn of 106840000. It has enough cash and short-term investments to cover this for at least one year.
- MAZE has $412.18M in cash and short term investments. This is enough to cover its annual cash burn of $106.84M.
- There are more short-term assets than long-term liabilities on the MAZE balance sheet.
- There are more short-term assets than short-term liabilities on the MAZE balance sheet.
- MAZE has a low debt to equity ratio of 0.17.
Negative Financial Indicators:
- MAZE profit margin has gone up by 31.77 percentage points in the past year, but the company is still unprofitable.
Do Wall Street analysts think it's a good time to buy Maze Therapeutics stock
Out of 4 Wall Street analysts who track MAZE, the consensus analyst rating on MAZE is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Maze Therapeutics stock forecast page.
MAZE Trading Indicators
MAZE Earnings
Last year, MAZE revenue was $20.00M. Over the past one years, MAZE's revenue has increased by 700% per year. This was faster than the Biotechnology industry average of 24.78%.
Dig into MAZE's earnings and revenue performance here.
What are MAZE executives and large shareholders up to?
Over the last 12 months, executives and large shareholders at MAZE have sold more shares than they have bought.
Harold Bernstein, Pres;CMO of MAZE, was the latest MAZE insider to sell. They sold $254,503.92 worth of MAZE stock on Sep 4, 2026.
Dig into more about who owns MAZE shares here.
Can I rely on MAZE as an income stream?
No, Maze Therapeutics doesn't provide an income stream by paying out dividends.
MAZE Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your MAZE buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly sufficient. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount, place a limit order.
Click the Open button and eToro will place the order.
If you need additional assistance buying stocks on eToro, click the how to video below:
Step 6: Watch your investment in MAZE
Now that you own some shares in MAZE, you'll want to stay up-to-date on your stock purchase.
Create a watchlist to track the latest developments regarding your MAZE stock.
MAZE Feed
How to Buy Stock in Maze Therapeutics
To reiterate, here are the 6 steps for buying Maze Therapeutics stock:
- Figure out where to buy Maze Therapeutics stock
- Open your brokerage account
- Put funds into your brokerage account
- Evaluate Maze Therapeutics stock
- Place your MAZE buy order
- Watch your investment in MAZE
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get updates on your investment in Maze Therapeutics, add MAZE to your watchlist below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.